These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 656013)

  • 1. Some properties of a high molecular vasopressor substance generated in human serum by incubation.
    Wurm H; Kenner T
    Basic Res Cardiol; 1978; 73(1):1-9. PubMed ID: 656013
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of a vasopressor substance in the incubated serum of patients with various hypertensive diseases.
    Maebashi M; Yoshinaga K
    Tohoku J Exp Med; 1984 Feb; 142(2):173-82. PubMed ID: 6719452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of circulating levels of vasoconstrictors on systemic pressor responsiveness to angiotensin II and norepinephrine.
    Clark KE
    Am J Obstet Gynecol; 1984 Jul; 149(5):480-4. PubMed ID: 6742015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the renal pressor substance of Grollman is related to angiotensin I.
    Schweikert JR; Carey RM; Liddle GW; Island DP
    Circ Res; 1972 Sep; 31(9):Suppl 2:132-42. PubMed ID: 4341472
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of vasopressor substances on the thoracic duct lymph flow.
    Fujii J; Wernze H
    Nature; 1966 May; 210(5039):956-7. PubMed ID: 4289662
    [No Abstract]   [Full Text] [Related]  

  • 6. A new pressor agent of renal origin: its differentiation from renin and angiotensin.
    Grollman A; Krishnamurty VS
    Am J Physiol; 1971 Nov; 221(5):1499-506. PubMed ID: 4330896
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives.
    Agha A; Schlüter H; König S; Biel K; Tepel M; Zidek W
    J Vasc Res; 1992; 29(3):281-9. PubMed ID: 1324015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of decrease in blood pressure and in blood pressure response to vasopressor agents during pregnancy in the rat.
    Teeuw AH; de Jong W
    Pflugers Arch; 1973 Jul; 341(3):197-208. PubMed ID: 4353221
    [No Abstract]   [Full Text] [Related]  

  • 9. A vasopressor factor partially purified from human parathyroid glands.
    Schlüter H; Quante C; Buchholz B; Dietl KH; Spieker C; Karas M; Zidek W
    Biochem Biophys Res Commun; 1992 Oct; 188(1):323-9. PubMed ID: 1417852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
    Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies of intracranial arterial spasm using aortic strip assays.
    Wilkins RH; Wilkins GK; Gunnells JC; Odom GL
    J Neurosurg; 1967 Dec; 27(6):490-500. PubMed ID: 4294336
    [No Abstract]   [Full Text] [Related]  

  • 12. Postglomerular vasoconstriction to angiotensin II and norepinephrine depends on intracellular calcium release.
    Imig JD; Cook AK; Inscho EW
    Gen Pharmacol; 2000 Jun; 34(6):409-15. PubMed ID: 11483290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cardiovascular reactivity in renal infarction hypertension.
    Basso N; de la Riva IJ
    Acta Physiol Lat Am; 1974; 24(2):109-18. PubMed ID: 4375405
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*.
    Asfar P; Chawla L; Lerolle N; Radermacher P
    Crit Care Med; 2014 Aug; 42(8):1961-3. PubMed ID: 25029144
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between angiotensin and bloodborne exogenous norepinephrine on the cat nictitating membrane in vivo.
    Cervoni P; Reit E
    J Pharmacol Exp Ther; 1971 Jun; 177(3):633-40. PubMed ID: 4328020
    [No Abstract]   [Full Text] [Related]  

  • 16. Responses of renal mechanoreceptors to vasopressor substances.
    Ueda H; Uchida Y; Kamisaka K
    Jpn Heart J; 1971 Jul; 12(4):347-53. PubMed ID: 4326803
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunopurification of a vasopressive substance from human serum with an anti-clonidine antibody.
    Dontenwill M; Molines A; Bennai F; Feldman J; Bricca G; Belcourt A; Bousquet P
    Ann N Y Acad Sci; 1995 Jul; 763():335-9. PubMed ID: 7677344
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic spectrum of vasopressor and vasodilator drugs.
    Lewis CM; Weil MH
    JAMA; 1969 May; 208(8):1391-8. PubMed ID: 4307223
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a vasopressor substance generated in human plasma by incubation.
    Yoshimura T; Matsui K; Ito M; Nakamura T; Maeyama M
    Life Sci; 1986 Feb; 38(5):425-30. PubMed ID: 3511345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II on the reactivity of isolated mesenteric vessels to norepinephrine in rats poisoned with cadmium.
    Skoczyńska A
    Int J Occup Med Environ Health; 1997; 10(1):67-77. PubMed ID: 9187048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.